Biblio

Export 795 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
C. J. D. Hardy, Buckley, A. H., Downey, L. E., Lehmann, M., Zimmerer, V. C., Varley, R. A., Crutch, S. J., Rohrer, J. D., Warrington, E. K., and Warren, J. D., The Language Profile of Behavioral Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 50, no. 2, pp. 359-71, 2016.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., VEGFR1 and VEGFR2 in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
J. Hartmann, Roßmeier, C., Riedl, L., Dorn, B., Fischer, J., Slawik, T., Fleischhaker, M., Hartmann, F., Egert-Schwender, S., Kehl, V., Haller, B., Schneider-Schelte, H., Dinkel, A., Jox, R. J., and Diehl-Schmid, J., Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset., J Alzheimers Dis, vol. 80, no. 1, pp. 283-297, 2021.
A. Hatami, Monjazeb, S., and Glabe, C., The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils., J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
S. Hatashita and Wakebe, D., Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging., J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
J. Haworth, Phillips, M., Newson, M., Rogers, P. J., Torrens-Burton, A., and Tales, A., Measuring Information Processing Speed in Mild Cognitive Impairment: Clinical Versus Research Dichotomy., J Alzheimers Dis, vol. 51, no. 1, pp. 263-75, 2016.
F. He, Luo, H., Yin, L., Roosaar, A., Axéll, T., Zhao, H., and Ye, W., Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up., J Alzheimers Dis, vol. 92, no. 1, pp. 171-181, 2023.
X. - Y. He, Isaacs, C., and Yang, S. - Y., Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 665-673, 2018.
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease., Nature, vol. 467, no. 7311, pp. 95-8, 2010.
D. Head, Bugg, J. M., Goate, A. M., Fagan, A. M., Mintun, M. A., Benzinger, T., Holtzman, D. M., and Morris, J. C., Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition., Arch Neurol, vol. 69, no. 5, pp. 636-43, 2012.
E. Healy, Impact of the MIND Diet on Cognition in Individuals with Dementia., J Alzheimers Dis, vol. 96, no. 3, pp. 967-977, 2023.
J. Heinrich, Vidal, J. - S., Simon, A., Rigaud, A. - S., Hanon, O., Epelbaum, J., Viollet, C., and Duron, E., Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 3, pp. 1133-1141, 2018.
K. Hensley and Kursula, P., Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau., J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
S. Hermes, Cady, J., Armentrout, S., O'Connor, J., Holdaway, S. Carlson, Cruchaga, C., Wingo, T., and Greytak, E. McRae, Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores., J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.
P. Heßmann, Seeberg, G., Reese, J. Peter, Dams, J., Baum, E., Müller, M. J., Dodel, R., and Balzer-Geldsetzer, M., Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings., J Alzheimers Dis, vol. 51, no. 2, pp. 545-61, 2016.
J. Hirt, Ballhausen, N., Hering, A., Kliegel, M., Beer, T., and Meyer, G., Social Robot Interventions for People with Dementia: A Systematic Review on Effects and Quality of Reporting., J Alzheimers Dis, vol. 79, no. 2, pp. 773-792, 2021.
T. Hisatsune, Kaneko, J., Kurashige, H., Cao, Y., Satsu, H., Totsuka, M., Katakura, Y., Imabayashi, E., and Matsuda, H., Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People., J Alzheimers Dis, vol. 50, no. 1, pp. 149-59, 2016.
H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline., J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G., Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial., J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
D. Horstkötter, Deckers, K., and Köhler, S., Primary Prevention of Dementia: An Ethical Review., J Alzheimers Dis, vol. 79, no. 2, pp. 467-476, 2021.
V. Hrincu, An, Z., Joseph, K., Jiang, Y. Fei, and Robillard, J. M., Dementia Research on Facebook and Twitter: Current Practice and Challenges., J Alzheimers Dis, vol. 90, no. 2, pp. 447-459, 2022.
S. Hsieh, Leyton, C. E., Caga, J., Flanagan, E., Kaizik, C., O'Connor, C. M., Kiernan, M. C., Hodges, J. R., Piguet, O., and Mioshi, E., The Evolution of Caregiver Burden in Frontotemporal Dementia with and without Amyotrophic Lateral Sclerosis., J Alzheimers Dis, vol. 49, no. 3, pp. 875-85, 2016.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Huang, Kritikos, M., Clouston, S. A. P., Deri, Y., Serrano-Sosa, M., Bangiyev, L., Santiago-Michels, S., Gandy, S., Sano, M., Bromet, E. J., and Luft, B. J., White Matter Connectivity in Incident Mild Cognitive Impairment: A Diffusion Spectrum Imaging Study of World Trade Center Responders at Midlife., J Alzheimers Dis, vol. 80, no. 3, pp. 1209-1219, 2021.

Pages